These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12095954)

  • 1. Murine models of paroxysmal nocturnal hemoglobinuria.
    Rosti V
    Ann N Y Acad Sci; 2002 Jun; 963():290-6. PubMed ID: 12095954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of paroxysmal nocturnal hemoglobinuria.
    Rosti V
    Haematologica; 2000 Jan; 85(1):82-7. PubMed ID: 10629597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxysmal nocturnal hemoglobinuria: the price for a chance.
    Bessler M
    Schweiz Med Wochenschr; 1996 Nov; 126(45):1912-21. PubMed ID: 8946596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutation and clonal selection in the pathogenesis and in the control of paroxysmal nocturnal hemoglobinuria.
    Bessler M; Hillmen P
    Semin Hematol; 1998 Apr; 35(2):149-67. PubMed ID: 9565157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiology of disease in patients with paroxysmal nocturnal hemoglobinuria.
    Bessler M; Hiken J
    Hematology Am Soc Hematol Educ Program; 2008; ():104-10. PubMed ID: 19074066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutral evolution in paroxysmal nocturnal hemoglobinuria.
    Dingli D; Luzzatto L; Pacheco JM
    Proc Natl Acad Sci U S A; 2008 Nov; 105(47):18496-500. PubMed ID: 19011109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.
    Kawagoe K; Kitamura D; Okabe M; Taniuchi I; Ikawa M; Watanabe T; Kinoshita T; Takeda J
    Blood; 1996 May; 87(9):3600-6. PubMed ID: 8611683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.
    Rosti V; Tremml G; Soares V; Pandolfi PP; Luzzatto L; Bessler M
    J Clin Invest; 1997 Sep; 100(5):1028-36. PubMed ID: 9276719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxysmal nocturnal hemoglobinuria: insights from recent advances in molecular biology.
    Bessler M; Schaefer A; Keller P
    Transfus Med Rev; 2001 Oct; 15(4):255-67. PubMed ID: 11668433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
    Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
    Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.
    Nishimura J; Smith CA; Phillips KL; Ware RE; Rosse WF
    Hematopathol Mol Hematol; 1998; 11(3-4):119-46. PubMed ID: 9844822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxysmal nocturnal hemoglobinuria: current issues in pathophysiology and treatment.
    Young NS
    Curr Hematol Rep; 2005 Mar; 4(2):103-9. PubMed ID: 15720958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paroxysmal nocturnal hemoglobinuria--consequences of a missing anchor].
    Korte W; Heijnen IA
    Ther Umsch; 2006 Jan; 63(1):71-7. PubMed ID: 16450736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease.
    Nishimura J; Murakami Y; Kinoshita T
    Am J Hematol; 1999 Nov; 62(3):175-82. PubMed ID: 10539884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the creation of animal models of paroxysmal nocturnal hemoglobinuria.
    Chen Y; Rong F
    Hematology; 2021 Dec; 26(1):491-496. PubMed ID: 34238137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxysmal nocturnal hemoglobinuria in children.
    van den Heuvel-Eibrink MM
    Paediatr Drugs; 2007; 9(1):11-6. PubMed ID: 17291133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Boccuni P; Del Vecchio L; Di Noto R; Rotoli B
    Crit Rev Oncol Hematol; 2000 Jan; 33(1):25-43. PubMed ID: 10714960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH) syndromes and expansion mechanism of a PNH clone.
    Shichishima T; Noji H
    Int J Hematol; 2006 Aug; 84(2):97-103. PubMed ID: 16926129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.